TerrAscend Stock (CSE: TER) (OTC: TRSSF) - Investor Dashboard

Follow Company

➔ TerrAscend
CSE Ticker:	TER
OTC Ticker:	TRSSF

Sector:	Healthcare
Industry:	Legal Cannabis
Country:	Canada

Employees:	20
Established:	2014
CEO:	Dr. Michael Nashat

Summary

Fiscal Year-End:	December
Facilities:	1
Dried Flower:	Production and Sale
Extracts:	Production
Number of Patients:	N/A
Headquarters:	Mississauga, ON

Financials (06/30/18)

Cash on hand:	$26.1mm
Fixed Investment:	$19.9mm
Shareholders’ Equity:	$64.3mm
Revenues – Last Quarter:	0
Adj. Gross Margin :	N/A
EPS :	-0.05

Capital Structure (08/24/18)

Last Financing:	47.7mm units at $1.10
Basic Shares:	95.8mm
Warrants:	51.6mm
Options:	.5mm
Diluted Shares:	153.9mm

Company Brief

TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market.

TerrAscend strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Terra Health Network Inc., a patient navigation and education platform led by health care professionals, and Solace Rx Inc., a drug preparation premises for non-cannabis formulations.

A Strong Growth Platform

Highlights

Licensed Producer with significant processing, formulation and manufacturing capabilities
Management comprised of leaders from healthcare, pharmaceutical, banking and cannabis industries
Strong pharmaceutical and distribution expertise
67,000 sq. ft. facility in Greater Toronto Area, nearby Pearson International Airport
Haven St. premium cannabis brand with 48 SKUs for the adult-use market in Canada

Growth Strategy

Focus on developing protectible intellectual property assets
Creating quality brands that resonate with patients and consumers
Ensure highest standard of ethics and corporate responsibility
Invest in business streams that will utilize cannabinoids
Planned entrance into the U.S. market supported by an agreement with Canopy Growth and Canopy Rivers

Differentiators

Focused on creating differentiated products for the global cannabinoid market
Experienced team with deep ties to global pharmaceutical distribution
Developing drug preparation premises for non-cannabinoid formulations
Leverage proximity to Toronto to distribute on behalf of third party LPs, with same-day delivery capabilities
Supply agreement with the Ontario Cannabis Store

The Four Pillars of TerrAscend

TerrAscend operates complementary business units that leverage its location, personnel, and strategic vision, providing a uniquely holistic business offering. TerrAscend believes that the cannabis space is much broader that just cultivating the crop, and as such, the company is working with strategic partners to develop businesses that complement the cannabis plant.

Advancing Research

Emphasis on developing protectible intellectual property
Advancing plant genetics and product formulations
Pharma-grade manufacturing facility

Building Brands

Developing trusted and recognized brands
Addressing needs of multiple cannabis business streams
Defining brands based on deep consumer insights

Promoting Responsibility

Ensuring highest standard of ethics and corporate integrity
Advocating responsible use of products
Exceeding industry and regulatory standards

Optimizing Wellness

Providing support for medical cannabis use
Guiding cannabis selection and consumption preferences
Enhancing the therapeutic application of cannabinoids

Curated Stories & News

Visit TerrAscend, Inc.
at www.terrascend.com.